Overview
Congenital muscular dystrophy due to dystroglycanopathy is a rare inherited muscle disease that is present from birth or becomes apparent in early infancy. It belongs to a group of conditions called dystroglycanopathies, which happen when a key protein in muscle cells — called alpha-dystroglycan — is not properly processed. This protein acts like a glue that holds muscle cells together and connects them to the surrounding tissue. When it does not work correctly, muscles become weak and break down over time. This condition affects not just the muscles but often the brain and eyes as well. Babies and children with this disease may have very low muscle tone (often called 'floppy baby' syndrome), delayed motor milestones, intellectual disability, and in some cases, structural brain abnormalities. Eye problems such as abnormal eye movements or vision loss can also occur. The severity varies widely — some children have a milder form with mainly muscle weakness, while others have a more severe form affecting the brain and eyes significantly. There is currently no cure for this condition. Treatment focuses on managing symptoms, maintaining function, and improving quality of life. This includes physical therapy, occupational therapy, respiratory support, and sometimes heart monitoring. Early diagnosis and a team of specialists can make a meaningful difference in day-to-day life and long-term outcomes.
Also known as:
Key symptoms:
Very low muscle tone from birth (floppy baby)Muscle weakness, especially in the arms and legsDelayed motor milestones such as late sitting, standing, or walkingIntellectual disability or learning difficultiesStructural brain abnormalities (such as abnormal brain folding)SeizuresEye problems including abnormal eye movements or vision lossBreathing difficulties due to weak respiratory musclesDifficulty swallowing or feeding in infancySpine curvature (scoliosis)Joint stiffness or contracturesHeart muscle problems (cardiomyopathy) in some casesElevated muscle enzyme levels in blood (creatine kinase)
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital muscular dystrophy due to dystroglycanopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital muscular dystrophy due to dystroglycanopathy at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital muscular dystrophy due to dystroglycanopathy.
Community
No community posts yet. Be the first to share your experience with Congenital muscular dystrophy due to dystroglycanopathy.
Start the conversation →Latest news about Congenital muscular dystrophy due to dystroglycanopathy
No recent news articles for Congenital muscular dystrophy due to dystroglycanopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific gene is causing my child's condition, and what does that mean for their prognosis?,What specialists should be part of my child's care team, and how often should we see each one?,Does my child need regular heart or breathing monitoring, and what signs should prompt an urgent visit?,Are there any clinical trials or research studies that my child might be eligible for?,What therapy services — physical, occupational, speech — does my child need, and how often?,What are the chances that future children could be affected, and should other family members be tested?,What support services or patient organizations can help our family connect with others living with this condition?
Common questions about Congenital muscular dystrophy due to dystroglycanopathy
What is Congenital muscular dystrophy due to dystroglycanopathy?
Congenital muscular dystrophy due to dystroglycanopathy is a rare inherited muscle disease that is present from birth or becomes apparent in early infancy. It belongs to a group of conditions called dystroglycanopathies, which happen when a key protein in muscle cells — called alpha-dystroglycan — is not properly processed. This protein acts like a glue that holds muscle cells together and connects them to the surrounding tissue. When it does not work correctly, muscles become weak and break down over time. This condition affects not just the muscles but often the brain and eyes as well. Babi
How is Congenital muscular dystrophy due to dystroglycanopathy inherited?
Congenital muscular dystrophy due to dystroglycanopathy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital muscular dystrophy due to dystroglycanopathy typically begin?
Typical onset of Congenital muscular dystrophy due to dystroglycanopathy is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Congenital muscular dystrophy due to dystroglycanopathy?
4 specialists and care centers treating Congenital muscular dystrophy due to dystroglycanopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.